To verify CHML’s role in tumor progression, we generated stable CHML-knockout Huh7 liver cancer cells using CRISPR-Cas9 and lentiviral transduction targeting exon 2, with PCR (500 bp band) and sequencing confirming mutations. This evidence concerns the gene CHML and neoplasm.